BIBX 1382
CAS: 196612-93-8
Rif. 3D-FB102671
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione |
Informazioni sul prodotto
- Falnidamol
- Bibx-1382
- Bibx-1382Bs
- N8-(3-Chloro-4-fluorophenyl)-N2-(1-methyl-4-piperidinyl)pyrimido[5,4-d]pyrimidine-2,8-diamine
- N~8~-(3-chloro-4-fluorophenyl)-N~2~-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-2,8-diamine
BIBX 1382 is a potent inhibitor of the epidermal growth factor receptor (EGFR) and has been shown to be active against solid tumours in cell culture. BIBX 1382 binds to the ATP-binding pocket of the EGFR kinase domain and inhibits the activation of this domain. This inhibition prevents the phosphorylation of downstream proteins, such as tyrosine kinases, which are required for cellular proliferation. BIBX 1382 has low bioavailability due to its poor solubility in water and a high degree of protein binding.